Product Information

PILOCARPINE HCL 5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2956 per EA under NDC 59651022401. Its NADAC has been published 276 times since Aug 11, 2021.

FDA first approved this application on Aug 13, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PILOCARPINE HCL 5 MG TABLET

pilocarpine hydrochloride
$0.2956per EA

Strength

5 mg/1

NDC

59651022401

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PILOCARPINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA212377

FDA Approved

8/13/2019

TE Code

AB

On Market Since

8/13/2019

Pharmacological Classes

Cholinergic Agonists
Cholinergic Muscarinic Agonists
Cholinergic Receptor Agonist

Price Statistics

The NADAC for PILOCARPINE HCL 5 MG TABLET has been published 276 times since Aug 11, 2021, and over the history we have for it it has declined 23.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2956 per EA
All-time high$0.3982 (Sep 15, 2021)
All-time low$0.1656 (Jul 17, 2024)
52-week high$0.3811
52-week low$0.2956
Median price$0.2705
Average price$0.2802
Largest weekly change+45.7% (Mar 20, 2024)
Weeks tracked276
Tracking sinceAug 11, 2021

Price History

1W

-4.8%

1M

-12.7%

3M

-10.3%

6M

-7.1%

1Y

-20.7%

3Y

+61.4%

5Y

+7.8%

All

-23.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the pilocarpine hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PILOCARPINE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PILOCARPINE HCL 5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.2956 per EA (NDC 59651022401), effective Nov 18, 2026.

How has the price of PILOCARPINE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for PILOCARPINE HCL 5 MG TABLET has declined 23.9%. It has been tracked across 276 weekly CMS publications since Aug 11, 2021.

What are the highest and lowest recorded NADAC prices for PILOCARPINE HCL 5 MG TABLET?

Since Aug 11, 2021, the NADAC for PILOCARPINE HCL 5 MG TABLET has ranged from a low of $0.1656 (Jul 17, 2024) to a high of $0.3982 (Sep 15, 2021), with a median of $0.2705 per EA.

Are there cheaper alternatives to PILOCARPINE HCL 5 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of PILOCARPINE HCL 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PILOCARPINE HCL 5 MG TABLET?

PILOCARPINE HCL 5 MG TABLET (NDC 59651022401) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.